Pub. Date : 2011 May 26
PMID : 21217772
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | In Jurkat leukaemic T cells as well as in primary human T cells, tetradecanoylphorbolacetate/ionomycin- and CD3/CD28-induced RelB degradation were impaired by a GSK-3beta-specific pharmacological inhibitor, an ectopically expressed dominant-negative GSK-3beta mutant and by small-interfering RNA-mediated silencing of GSK-3beta expression. | Tetradecanoylphorbol Acetate | glycogen synthase kinase 3 beta | Homo sapiens |
| 2 | In Jurkat leukaemic T cells as well as in primary human T cells, tetradecanoylphorbolacetate/ionomycin- and CD3/CD28-induced RelB degradation were impaired by a GSK-3beta-specific pharmacological inhibitor, an ectopically expressed dominant-negative GSK-3beta mutant and by small-interfering RNA-mediated silencing of GSK-3beta expression. | Tetradecanoylphorbol Acetate | glycogen synthase kinase 3 beta | Homo sapiens |
| 3 | In Jurkat leukaemic T cells as well as in primary human T cells, tetradecanoylphorbolacetate/ionomycin- and CD3/CD28-induced RelB degradation were impaired by a GSK-3beta-specific pharmacological inhibitor, an ectopically expressed dominant-negative GSK-3beta mutant and by small-interfering RNA-mediated silencing of GSK-3beta expression. | Tetradecanoylphorbol Acetate | glycogen synthase kinase 3 beta | Homo sapiens |